Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
25R insulin lispro mix vs Humalog Mix25 in type 2 diabetes
CTR20210044Phase 3Completed
- Sponsor
- Tonghua Dongbao
- Start
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin lispro mix25 in type 2 diabetes mellitus (T2DM), sponsored by Tonghua Dongbao. Started Jan 2021; status: completed.
02
Drugs
insulin lispro mix25
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20210044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210044.